Innovative MedTech, Inc.
IMTH
$0.15
$0.0215.39%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -10.88% | 2.98% | -4.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -10.88% | 2.98% | -4.59% |
| Cost of Revenue | -- | -- | -18.47% | -80.68% | -- |
| Gross Profit | -- | -- | 1.01% | 144.74% | -- |
| SG&A Expenses | -93.45% | 1,045.20% | 204.16% | 1,359.39% | 131.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -93.45% | 1,045.20% | 100.02% | 181.99% | -38.16% |
| Operating Income | 93.45% | -1,045.20% | -463.15% | -280.38% | 6.17% |
| Income Before Tax | 86.42% | -753.73% | -435.13% | -666.63% | -8.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 86.42% | -753.73% | -435.13% | -666.63% | -8.19% |
| Earnings from Discontinued Operations | 164.29% | 73.71% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.24% | -497.71% | -435.13% | -666.63% | -13.79% |
| EBIT | 93.45% | -1,045.20% | -463.15% | -280.38% | 6.17% |
| EBITDA | 94.74% | -1,184.56% | -565.64% | -282.54% | 5.95% |
| EPS Basic | 96.05% | -308.99% | -308.97% | -495.63% | -13.76% |
| Normalized Basic EPS | 94.53% | -489.47% | -306.12% | -179.77% | -8.47% |
| EPS Diluted | 96.05% | -308.99% | -308.97% | -478.77% | -7.50% |
| Normalized Diluted EPS | 94.53% | -489.47% | -306.12% | -179.77% | -8.47% |
| Average Basic Shares Outstanding | 149.01% | 46.01% | 31.02% | 28.57% | 0.00% |
| Average Diluted Shares Outstanding | 149.01% | 46.01% | 31.02% | 28.57% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |